Stocks and Investing Stocks and Investing
Mon, December 12, 2022
[ 12:00 AM ] - WOPRAI
Seth Seifman Maintained (BA) at Buy with Increased Target to $200 on, Dec 12th, 2022
[ 12:00 AM ] - WOPRAI
Kate McShane Upgraded (BBY) to Hold and Increased Target to $83 on, Dec 12th, 2022
[ 12:00 AM ] - WOPRAI
Joanne Wuensch Upgraded (BDX) to Hold and Increased Target to $250 on, Dec 12th, 2022
[ 12:00 AM ] - WOPRAI
Andrew Berens Maintained (BGNE) at Buy with Increased Target to $236 on, Dec 12th, 2022
[ 12:00 AM ] - WOPRAI
Edward White Maintained (ACET) at Strong Buy with Increased Target to $38 on, Dec 12th, 2022
[ 12:00 AM ] - WOPRAI
Joanne Wuensch Maintained (ABT) at Strong Buy with Increased Target to $125 on, Dec 12th, 2022
[ 12:00 AM ] - WOPRAI
Martin Yang Maintained (AAPL) at Buy with Decreased Target to $170 on, Dec 12th, 2022
[ 12:00 AM ] - WOPRAI
Arvind Ramnani Downgraded (ACN) to Sell on, Dec 12th, 2022
[ 12:00 AM ] - WOPRAI
Carter Gould Maintained (ACLX) at Buy with Increased Target to $38 on, Dec 12th, 2022
[ 12:00 AM ] - WOPRAI
Gil Blum Maintained (ACLX) at Strong Buy with Increased Target to $35 on, Dec 12th, 2022
[ 12:00 AM ] - WOPRAI
Joseph France Upgraded (ACHC) to Strong Buy and Held Target at $95 on, Dec 12th, 2022
[ 12:00 AM ] - WOPRAI
Ben Hendrix Maintained (ACHC) at Buy with Decreased Target to $93 on, Dec 12th, 2022
[ 12:00 AM ] - WOPRAI
Mark Massaro Initiated (BNGO) at Strong Buy and Held Target at $35 on, Dec 12th, 2022
[ 12:00 AM ] - WOPRAI
Swayampakula Ramakanth Initiated (AFMD) at Strong Buy and Held Target at $60 on, Dec 12th, 2022
[ 12:00 AM ] - WOPRAI
Daina Graybosch Maintained (AFMD) at Buy with Decreased Target to $60 on, Dec 12th, 2022
[ 12:00 AM ] - WOPRAI
Do Kim Maintained (AFMD) at Buy with Decreased Target to $60 on, Dec 12th, 2022
[ 12:00 AM ] - WOPRAI
James Shin Maintained (AFMD) at Buy with Decreased Target to $70 on, Dec 12th, 2022
[ 12:00 AM ] - WOPRAI
Dan Dolev Maintained (ADP) at Strong Buy with Increased Target to $285 on, Dec 12th, 2022
[ 12:00 AM ] - WOPRAI
Joseph Catanzaro Initiated (ACRV) at Buy and Held Target at $25 on, Dec 12th, 2022
[ 12:00 AM ] - WOPRAI
Akash Tewari Initiated (ACRV) at Strong Buy and Held Target at $17 on, Dec 12th, 2022
[ 12:00 AM ] - WOPRAI
Joseph Thome Initiated (ACRV) at Buy on, Dec 12th, 2022
[ 12:00 AM ] - WOPRAI
Tyler Radke Maintained (ADBE) at Hold with Decreased Target to $337 on, Dec 12th, 2022
[ 12:00 AM ] - WOPRAI
Karl Keirstead Maintained (ADBE) at Hold with Increased Target to $350 on, Dec 12th, 2022
[ 12:00 AM ] - WOPRAI
Christopher Rolland Initiated (ADI) at Buy and Held Target at $205 on, Dec 12th, 2022
[ 12:00 AM ] - WOPRAI
Joanne Wuensch Maintained (ZBH) at Hold with Increased Target to $130 on, Dec 12th, 2022
[ 12:00 AM ] - WOPRAI
Kate McShane Maintained (ASO) at Strong Buy with Increased Target to $65 on, Dec 12th, 2022
[ 12:00 AM ] - WOPRAI
Kristine Liwag Upgraded (CAE) to Buy on, Dec 12th, 2022
[ 12:00 AM ] - WOPRAI
Jordan Bender Downgraded (BYD) to Hold on, Dec 12th, 2022
[ 12:00 AM ] - WOPRAI
Jared Garber Downgraded (CAKE) to Strong Sell and Decreased Target to $29 on, Dec 12th, 2022
[ 12:00 AM ] - WOPRAI
Raghuram Selvaraju Maintained (URGN) at Strong Buy with Decreased Target to $23 on, Dec 12th, 2022

Raghuram Selvaraju Maintained (URGN) at Strong Buy with Decreased Target to $23 on, Dec 12th, 2022


Published on 2024-10-28 00:31:31 - WOPRAI, Raghuram Selvaraju
  Print publication without navigation


Raghuram Selvaraju of HC Wainwright & Co., Maintained "UroGen Pharma Ltd." (URGN) at Strong Buy with Decreased Target from $26 to $23 on, Dec 12th, 2022.

Raghuram, nor any peers, have made any analyst calls on URGN in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources